The role of Asprosin in patients with dilated cardiomyopathy.

Ming-Shien WenChao-Yung WangJih-Kai YehChun-Chi ChenMing-Lung TsaiMing-Yun HoKuo-Chun HungI-Chang Hsieh

Published in: BMC cardiovascular disorders (2020)

In patients with DCM, elevated plasma asprosin levels are associated with less adverse cardiovascular events in five years. The underlying protective mechanisms of asprosin may be linked to its functions relating to enhanced mitochondrial respiration under hypoxia.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
oxidative stress
endothelial cells
emergency department
adverse drug